Say something

GE plans to invest $6 Billion on healthcare
GE plans to invest $6 Billion on healthcare

GE Healthcare, the $17-billion healthcare arm of General Electric launched new, low cost products, aimed at developing markets such as India, as the company seeks to spend around $6 billion on its global strategy to grow its revenues from emerging markets.

Ranbaxy starts phase III study of anti-malaria drug
Ranbaxy starts phase III study of anti-malaria drug

Ranbaxy Laboratories announced that its new anti-malarial combination drug is now undergoing final stage of development. In its press-release, the company said that the drug is targeted at patients in developing countries with the aim of significantly improving upon the conventional options available for the treatment of P falciparum malaria.

The e Factor
The e Factor

Modern electronics is revolutionising healthcare like never before. While bringing superior diagnostic and therapeutic capabilities, electronic and semiconductor technologies are also making […]

NEWS REVIEW
NEWS REVIEW

[This article was published in the May 2009 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]

News Review

whatsapp--v1